Telix Pharmaceuticals | Betriebsergebnis



Operating Profit Veränderung Datum
Cochlear AUD 274.6M 54.5M 2024-12
CSL USD 1.98B 778M 2024-12
Integral Diagnostics AUD 19.28M 73.95M 2024-06
Mayne Pharma AUD -3300000 15.67M 2024-06
Medical Developments International AUD 182K 20.42M 2024-12
Mesoblast -45727000 22.22M 2024-06
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Pacific Edge NZD -15314000 7.45M 2024-09
Paradigm Biopharmaceuticals AUD -5930700 3.79M 2024-12
Polynovo AUD 513K 902K 2024-06
PYC Therapeutics AUD -25891160 14.18M 2024-12
Ramsay Health Care AUD 200M 285.4M 2024-12
ResMed USD 417.24M 29.93M 2024-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12



Telix Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2025.